GOSS
GOSS
NASDAQ · Biotechnology

Gossamer Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.37
+0.00 (+0.54%)
As of May 9, 1:47 AM ET ·
Analyst Consensus
Buy
16
Analysts
High
Coverage
Buy 10 63%
Hold 5 31%
Sell 1 6%
Price Target
Analyst Price Target +7,312.1% upside
Low Target $18.46
Average Target $27.41
High Target $44.08
Current Price $0.37
Current
$0.37
Target
$27.41
$18.46 $27.41 avg $44.08
Scenario Analysis
Bear Case
$18.46
4,891.9%
Low target
Base Case
$27.41
+7,312.1%
Avg target
Bull Case
$44.08
+11,820.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$3.87
-90.4% from high
52-Week Low
$0.32
+15.6% from low
Target vs 52W High
$27.41
+608.3% vs high
Next Earnings Report
May 12, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.17
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%